Stay updated on MGD013 and Brivanib in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the MGD013 and Brivanib in Liver Cancer Clinical Trial page.

Latest updates to the MGD013 and Brivanib in Liver Cancer Clinical Trial page
- Check7 days agoChange DetectedThe record history now shows a new revision, v3.6.3, added to the history. The previous revision, v3.6.0, has been removed.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe study record now shows recruitment has closed ('No longer looking for participants') and has been updated to version v3.6.0, reflecting the latest revision of the record.SummaryDifference0.6%

- Check28 days agoChange DetectedNew version entry v3.5.5 appears in the history, replacing the prior v3.5.4. This documents an update to the page's release/versioning information.SummaryDifference0.1%

- Check50 days agoChange DetectedA new revision entry (v3.5.4) was added to the study record history, superseding the previous v3.5.3. This indicates an update to the record's revision metadata.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page’s footer revision identifier was updated from “v3.5.0” to “v3.5.3.” This reflects a change in the site’s release/version metadata without altering the study record information shown.SummaryDifference0.1%

- Check107 days agoChange DetectedA new revision (v3.5.0) was added and the previous revision (v3.4.3) was removed from the study record history.SummaryDifference0.1%

Stay in the know with updates to MGD013 and Brivanib in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MGD013 and Brivanib in Liver Cancer Clinical Trial page.